Lynda.com upgrades to LinkedIn Learning, Thursday, Sept. 5
Lynda.com will be unavailable for up to 18-hours on Thursday, Sept. 5, during the upgrade to LinkedIn Learning.
Lynda.com will be unavailable for up to 18-hours on Thursday, September 5, during the upgrade to LinkedIn Learning.
About the transition to LinkedIn Learning
Students, faculty, and staff members who have logged into Lynda.com will automatically receive a login invitation from LinkedIn Learning upon the upgrade’s completion.
LinkedIn Learning provides access to the same industry-leading content from Lynda.com. Since LinkedIn acquired Lynda.com, all currently enrolled UC students, faculty, and staff will have free access to LinkedIn Learning. Content that was previously available through Lynda.com will also be available in LinkedIn Learning.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.